Sciencast Management LP Takes $349000 Position in Hologic, Inc. (HOLX)

Current trade price levels places HOLX's stock about -19.25% away from the 52-week high and closed 7.51% away from the 52-week low. State Street Corp now owns 12,710,718 shares of the medical equipment provider's stock worth $540,846,000 after acquiring an additional 189,572 shares during the period. A ratio of 1.5 will suggest that the company has $1.5 of liquid assets available to pay off $1 of its current liabilities. Commonwealth Bank of Australia now owns 2,533 shares of the medical equipment provider's stock worth $114,000 after buying an additional 600 shares during the period. Squarepoint Ops LLC now controls 342,748 shares worth $15,554,000. Vanguard Group Inc. increased its stake in shares of Hologic by 4.2% in the second quarter.

As of the end of the quarter Curbstone Financial Management Corp had bought a total of 8,778 shares growing its stake by 101.2%. National Asset Management Inc. purchased a new stake in shares of Hologic during the second quarter valued at $203,000.

COPYRIGHT VIOLATION NOTICE: "Hologic, Inc".

Receive Hologic, Inc. News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hologic, Inc. with MarketBeat.com's FREE daily email newsletter. If you are viewing this story on another site, it was stolen and reposted in violation of United States & global copyright and trademark legislation.

08/03/2017 - Hologic, Inc. had its "sector perform" rating reiterated by analysts at RBC Capital. Over the last three months, insiders sold 18,745 shares of company stock worth $768,189. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. BidaskClub lowered shares of Hologic from a hold rating to a sell rating in a research note on Wednesday, August 9th. The total value of its holdings increased 31.7%. The institutional investor held 73,275 shares of the technology company at the end of 2017Q2, valued at $11.07M, down from 78,092 at the end of the previous reported quarter. The disclosure for this sale can be found here. Its investment was worth $15,000 a decrease of 68.1% as of the end of the quarter.

Several analysts have recently commented on HOLX shares. Finally, Deutsche Bank AG reduced their target price on Hologic from $51.00 to $49.00 and set a "buy" rating for the company in a report on Thursday, August 3rd. The firm has "Buy" rating by Bank of America given on Friday, July 24. Zacks Investment Research cut Hologic from a "hold" rating to a "sell" rating in a research note on Wednesday, July 12th.

Hologic, Inc. (NASDAQ:HOLX) [Trend Analysis] share price swings at $37.78 with percentage change of 0.21% in most recent trading session.

Analysts have given a mean recommendation of 2.00 on this stock (A rating of less than 2 means buy, "hold" within the 3 range, "sell" within the 4 range, and "strong sell" within the 5 range). Hologic has an average rating of "Hold" and a consensus target price of $48.15. In the past 52 weeks the company's stock price has moved within the range of $35.15 to $46.80. (NASDAQ:HOLX) traded down 2.39% during trading on Monday, hitting $36.79. HOLX has diverse figures for different time frames; starting from week's performance dropped 1.64% in last five regular trading sessions. The firm has a market cap of $10.57 billion, a P/E ratio of 14.04 and a beta of 0.91.

This particular stock's 5-day moving average is 37.17, its 20-day moving average is 37.64 and its 100-day moving average is 41.67.

Hologic (NASDAQ:HOLX) last issued its earnings results on Wednesday, May 10th. The medical equipment provider reported $0.50 EPS for the quarter, beating analysts' consensus estimates of $0.49 by $0.01. Hologic had a return on equity of 27.17% and a net margin of 11.57%. The business had revenue of $715.40 million for the quarter, compared to analysts' expectations of $685.24 million. They expect $0.60 EPS, up 3.45% or $0.02 from last year's $0.58 per share. Hologic's revenue was up 12.4% on a year-over-year basis.

The Average Earnings Estimate for the Current Fiscal quarter is $0.49 per share, according to consensus of 17 analysts.

Hologic, Inc.is a developer, manufacturer and supplier of diagnostics products, medical imaging systems and surgical products with an emphasis on women's health. The Firm operates through four divisions: Diagnostics, Breast Health, GYN Surgical and Skeletal Health.

Related:

Comments

Latest news

Malala starts at Oxford University
Malala Yousafzai's story will always be an inspiring one. "Today, I attend my first lectures at Oxford", Malala wrote on Twitter. Many of her posts advocated for the rights of girls to receive a formal education which angered the ultra-conservative Taliban.

Garcia stuns new No 1 Halep to win China Open
Obviously her withdrawal yesterday also had to do with a little bit of fatigue as she played and won 11 matches in a row between Wuhan and Beijing.

Iceland Becomes Smallest Nation in History to Qualify for World Cup
Incredibly, Iceland is now the smallest ever nation to qualify for the World Cup in the history of the world's biggest tournament. Ukraine and Croatia were locked at 0-0 in a battle for the one play-off spot when Andrej Kramaric converted a Luka Modric pass.

Iranian minister slams Trump's threats to 'decertify' nuclear deal
Sanders said the president "wants to look for a broad strategy that addresses all of those problems, not just one-offing those". The Trump administration has to certify to Congress on October 15 that Iran is compliant with the nuclear deal reached in 2015.

Henrik Lundqvist backs Rangers to first win after shaky start
The first was an Andrew Shaw kick-in that was called a goal at 6:24, sending Lundqvist into a tizzy, demanding the refs review it. From there, the Rangers and Lundqvist battened down the hatches and collected their first hard-earned victory of the season.

Other news